Labeler
Sanofi Vaccines US Inc. NDC Codes
Sanofi Vaccines US Inc. lists 24 finished drug products in the FDA NDC Directory under NDC labeler code 49281.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Fluzone Tiv Sh 2026, Fluzone Trivalent Northern Hemisphere, Beyfortus, Nuvaxovid 2026-27, Fluzone High Dose Northern Hemisphere, Flublok Trivalent Northern Hemisphere, Fluzone HD Tiv Sh 2026, MenQuadfi, Imovax Rabies, Quadracel, Tenivac, Pentacel, Adacel TDaP, Menactra, Daptacel
- Active ingredients
- Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated), Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated), Clostridium tetani toxoid antigen (Formaldehyde inactivated), Influenza a virus a/michigan/105/2025 san-049a (H3n2) antigen (Formaldehyde inactivated), Influenza b virus b/tokyo/eis13-175/2025 antigen (Formaldehyde inactivated), Influenza a virus a/singapore/gp20238/2024 ivr-277 (H3n2) antigen (Formaldehyde inactivated), Influenza b virus b/michigan/01/2021 antigen (Formaldehyde inactivated), Bordetella pertussis toxoid antigen (Glutaraldehyde inactivated), Bordetella pertussis filamentous hemagglutinin antigen (Formaldehyde inactivated), Bordetella pertussis pertactin antigen, Bordetella pertussis fimbriae 2/3 antigen, Nirsevimab
- NDC labeler codes
- 49281
- Strengths
- Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL; Bordetella pertussis pertactin antigen 3 ug/.5mL; Bordetella pertussis fimbriae 2/3 antigen 5 ug/.5mL; Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 60 ug/.5mL; Influenza a virus a/singapore/gp20238/2024 ivr-277 (H3n2) antigen (Formaldehyde inactivated) 15 ug/.5mL; Influenza b virus b/michigan/01/2021 antigen (Formaldehyde inactivated) 15 ug/.5mL; Nirsevimab 100 mg/mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL; Bordetella pertussis filamentous hemagglutinin antigen (Formaldehyde inactivated) 5 ug/.5mL; Nvx-cov2928 5 ug/.5mL; Influenza a virus a/michigan/105/2025 san-049a (H3n2) antigen (Formaldehyde inactivated) 60 ug/.5mL; Influenza b virus b/tokyo/eis13-175/2025 antigen (Formaldehyde inactivated) 60 ug/.5mL; Influenza a virus a/missouri/11/2025 (H1n1) recombinant hemagglutinin antigen 45 ug/.5mL; Influenza a virus a/darwin/1415/2025 (H3n2) recombinant hemagglutinin antigen 45 ug/.5mL; Influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen 45 ug/.5mL; Influenza a virus a/singapore/gp20238/2024 ivr-277 (H3n2) antigen (Formaldehyde inactivated) 60 ug/.5mL; Influenza b virus b/michigan/01/2021 antigen (Formaldehyde inactivated) 60 ug/.5mL; Influenza a virus a/michigan/105/2025 san-049a (H3n2) antigen (Formaldehyde inactivated) 15 ug/.5mL
- Dosage forms
- Injection, Suspension, Injection, Injection, Solution, Kit, Injection, Powder, Lyophilized, For suspension
- Routes
- Intramuscular, Subcutaneous, Intradermal
- Drug classes (FDA established)
- Inactivated Bordetella Pertussis Vaccine, Inactivated Poliovirus Vaccine, Inactivated Clostridium Tetani Vaccine, Inactivated Corynebacterium Diphtheriae Vaccine, Inactivated Meningococcal Vaccine, Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody, Inactivated Salmonella Typhi Vaccine, Skin Test Antigen, Tuberculosis Skin Test, Osmotic Laxative, Live Attenuated Yellow Fever Virus Vaccine
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 37
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Nuvaxovid 2026-27nvx-cov2928 | Nvx-cov2928 5 ug/.5mL | Injection, SuspensionIntramuscular | 49281-026 | 49281-0026-50 | — |
| Fluzone High Dose Northern Hemisphereinfluenza a virus a/switzerland/6849/2025 ivr-278 (a/missouri/11/2025 pdm09-like virus) (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 60 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-126 | 49281-0126-65 | — |
| Flublok Trivalent Northern Hemisphereinfluenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/1415/2025 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen | Influenza a virus a/missouri/11/2025 (H1n1) recombinant hemagglutinin antigen 45 ug/.5mL + 2 more ingredients | InjectionIntramuscular | 49281-726 | 49281-0726-10 | — |
| Fluzone HD Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 60 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-016 | 49281-0016-50 | — |
| Fluzone Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-315 | 49281-0315-15 | — |
| Fluzone Tiv Sh 2026influenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-626 | 49281-0626-50 | — |
| Fluzone Trivalent Northern Hemisphereinfluenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-645 | 49281-0645-15 | — |
| Fluzone Trivalent Northern Hemisphereinfluenza a virus a/switzerland/6849/2025 ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | Influenza a virus a/switzerland/6849/2025 ivr-278 (H1n1) antigen (Formaldehyde inactivated) 15 ug/.5mg + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-426 | 49281-0426-50 | — |
| Beyfortusnirsevimab | Nirsevimab 100 mg/mL | InjectionIntramuscular | 49281-575 | 49281-0575-0049281-0575-15 | — |
| Beyfortusnirsevimab | Nirsevimab 100 mg/mL | InjectionIntramuscular | 49281-574 | 49281-0574-1549281-0574-88 | — |
| MenQuadfineisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen | Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen 10 ug/.5mL + 3 more ingredients | Injection, SolutionIntramuscular | 49281-590 | 49281-0590-0149281-0590-0549281-0590-10 | — |
| Imovax Rabiesrabies virus strain pm-1503-3m antigen (propiolactone inactivated) and water | — | Kit | 49281-252 | 49281-0252-51 | — |
| Quadraceldiphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | 49281-564 | 49281-0564-1049281-0564-15 | — |
| Tenivacclostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL | Injection, SuspensionIntramuscular | 49281-215 | 49281-0215-1049281-0215-15 | — |
| Pentaceldiphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus b conjugate (tetanus toxoid conjugate) vaccine | — | Kit | 49281-511 | 49281-0511-05 | — |
| Adacel TDaPclostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL + 5 more ingredients | Injection, SuspensionIntramuscular | 49281-400 | 49281-0400-1049281-0400-20 | — |
| Menactraneisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen | Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen 4 ug/.5mL + 3 more ingredients | Injection, SolutionIntramuscular | 49281-589 | 49281-0589-05 | — |
| Daptacelcorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL + 5 more ingredients | Injection, SuspensionIntramuscular | 49281-286 | 49281-0286-0149281-0286-0549281-0286-10 | — |
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | 49281-790 | 49281-0790-2049281-0790-51 | — |
| ActHIBhaemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | — | Kit | 49281-545 | 49281-0545-03 | — |
| Ipolpoliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated) | Poliovirus type 1 antigen (Formaldehyde inactivated) 40 [D'ag'U]/.5mL + 2 more ingredients | Injection, SuspensionIntramuscular | 49281-860 | 49281-0860-10 | — |
| Tubersoltuberculin purified protein derivative | Tuberculin purified protein derivative 5 [iU]/.1mL | Injection, SolutionIntradermal | 49281-752 | 49281-0752-2149281-0752-22 | — |
| Diluentsodium chloride | Sodium chloride 4.5 mg/.5mL | InjectionSubcutaneous | 49281-912 | 49281-0912-0549281-0912-10 | — |
| Yf-Vaxyellow fever virus strain 17d-204 live antigen | Yellow fever virus strain 17d-204 live antigen 4.74 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | 49281-915 | 49281-0915-0149281-0915-05 | — |
Sanofi Vaccines US Inc.: common questions
- What is Sanofi Vaccines US Inc.'s NDC labeler code?
- 49281. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sanofi Vaccines US Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.